This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pengo, V. Articles by Iliceto, S. Search for Related Content PubMed PubMed Citation Articles by Pengo, V. Articles by Iliceto, S. Social Bookmarking                         What's this?

Low-Intensity Oral Anticoagulant Plus Low-Dose Aspirin During the First Six Months Versus Standard-Intensity Oral Anticoagulant Therapy After Mechanical Heart Valve Replacement: A Pilot Study of Low-Intensity Warfarin and Aspirin in Cardiac Prostheses (LIWACAP)

Clinical Cardiology, Thrombosis Centre, University of Padova, vittorio.pengo{at}unipd.it

Gualtiero Palareti, MD

Department of Angiology & Blood Coagulation Marino Golinelli, University of Bologna

Umberto Cucchini, MD

Clinical Cardiology, Thrombosis Centre, University of Padova

Maurizio Molinatti, MD

Division of Transfusion Medicine, Maria Vittoria Hospital, Torino

Roberto Del Bono, MD

Clinical Pathology, Brescia Hospital

Franco Baudo, MD

Division of Hematology Niguarda Ca'Granda, Milano

Angelo Ghirarduzzi, MD

Department of Medicine, Reggio Emilia Hospital, Italy

Cinzia Pegoraro, MD

Clinical Cardiology, Thrombosis Centre, University of Padova

Sabino Iliceto

The objective of this study was to evaluate the safety and efficacy of low-intensity warfarin treatment plus aspirin during the first 6 months after surgery in patients undergoing heart valve substitution with mechanical prostheses. Vitamin K antagonists (VKA) are able to reduce but not eliminate thrombosis and systemic embolism in patients with mechanical heart valves. The intensity of treatment and additional use of aspirin in these patients is still controversial. Consecutive patients undergoing aortic or mitral valve replacement (or a combination of the two) with mechanical prostheses were invited to participate in the study. After stratifying for site of prosthesis, patients were randomized to receive low intensity VKA treatment (target INR 2.5) plus aspirin (100 mg/day) for the first six months (Group A) or standard-intensity (INR target 3.7) VKA treatment (Group B). Mean follow-up was 1.5 years. Principal outcome events were systemic embolism, major bleeding, and vascular death. A total of 94 patients in Group A and 104 in Group B were randomized and followed up for 144 and 163 patient years, respectively. There were 5 (5%) events in Group A (4 major bleeding events and 1 vascular death) and 4 (4%) in group B (2 major bleeding events and 2 ischemic stroke). All the events except 1 occurred within the first 6 months after surgery. Cumulative incidence of primary outcome events was 5.8% (95% CI 0.9 to 10.7) in Group A and 4.3% (95% CI 0,2 to 8.4) in Group B (p=0.6). Low-intensity treatment plus aspirin during the first six months after surgery appears to be as effective and safe as moderate-high-intensity anticoagulation.

Key Words: Prostheses • Warfarin • Stroke • Bleeding.

Clinical and Applied Thrombosis/Hemostasis, Vol. 13, No. 3, 241-248 (2007)
DOI: 10.1177/1076029607302544


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?